Drug:
Reaction: HOSPITALISATION
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25138793 |
AU |
||
Death, Hospitalisation, |
||||
DENOSUMAB, |
||||
| 2 | 25138976 |
CA |
58 | 2 |
Hospitalisation, Weight increased, Abdominal distension, Constipation, Fatigue, Product distribution issue, Therapy cessation, |
||||
OBETICHOLIC ACID, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, |
||||
| 3 | 25139049 |
US |
||
Hospitalisation, |
||||
AMBRISENTAN, |
||||
| 4 | 25139148 |
JP |
58 | 2 |
Hospitalisation, Off label use, |
||||
FILGRASTIM, |
||||
| 5 | 25139160 |
US |
2 | |
Hospitalisation, Hydronephrosis, Product administration interrupted, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, ARMODAFINIL, ONDANSETRON HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ARIPIPRAZOLE, |
||||
| 6 | 25139167 |
US |
46 | 1 |
Hospitalisation, |
||||
| 7 | 25139208 |
JP |
||
Hospitalisation, |
||||
DAPRODUSTAT, VADADUSTAT, |
||||
| 8 | 25139251 |
US |
85 | 1 |
Hospitalisation, |
||||
| 9 | 25139253 |
US |
91 | 2 |
Hospitalisation, |
||||
POMALIDOMIDE, |
||||
| 10 | 25139286 |
US |
78 | 2 |
Hospitalisation, |
||||
| 11 | 25139426 |
CA |
81 | 1 |
Acute kidney injury, Respiratory syncytial virus infection, Thrombosis, Diabetes mellitus, Crohn^s disease, Hospitalisation, |
||||
RISANKIZUMAB-RZAA, |
||||
| 12 | 25139526 |
JP |
||
Hospitalisation, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 13 | 25139759 |
JP |
||
Hospitalisation, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 14 | 25139808 |
CN |
||
Hospitalisation, Incorrect dose administered, |
||||
| 15 | 25139944 |
JP |
||
Hospitalisation, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 16 | 25140031 |
AU |
||
Death, Hospitalisation, |
||||
DENOSUMAB, |
||||
| 17 | 25140066 |
GB |
1 | |
Hospitalisation, |
||||
CLOZAPINE, |
||||
| 18 | 25140080 |
AU |
1 | |
Death, Hospitalisation, |
||||
DENOSUMAB, |
||||
| 19 | 25140118 |
AU |
||
Death, Hospitalisation, |
||||
DENOSUMAB, |
||||
| 20 | 25140217 |
AU |
||
Death, Hospitalisation, |
||||
DENOSUMAB, |
||||
| 21 | 25140250 |
US |
66 | 1 |
Hospitalisation, |
||||
LENALIDOMIDE, |
||||
| 22 | 25140431 |
GB |
1 | |
Hospitalisation, |
||||
CLOZAPINE, |
||||
| 23 | 25140529 |
US |
2 | |
Hospitalisation, |
||||
AMBRISENTAN, |
||||
| 24 | 25140534 |
AU |
31 | 1 |
Hospitalisation, |
||||
CLOZAPINE, |
||||
| 25 | 25140682 |
US |
2 | |
Death, Hospitalisation, |
||||
SITAGLIPTIN, |
||||
| 26 | 25140707 |
GB |
2 | |
Hospitalisation, |
||||
CLOZAPINE, |
||||
| 27 | 25140908 |
GB |
2 | |
Agranulocytosis, Hospitalisation, Malaise, Tooth abscess, White blood cell count decreased, Neutrophil count decreased, |
||||
CLOZAPINE, |
||||
| 28 | 25140933 |
US |
62 | 1 |
Hospitalisation, |
||||
| 29 | 25141183 |
JP |
||
Hospitalisation, |
||||
METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 30 | 25141245 |
2 | ||
Hospitalisation, |
||||
OMALIZUMAB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 31 | 25141311 |
RS |
45 | 1 |
Suicidal ideation, Adverse event, Sedation, Sluggishness, Impaired work ability, Regressive behaviour, Asthenia, Apathy, Bedridden, Social problem, Hospitalisation, Weight increased, Listless, Self esteem decreased, |
||||
OLANZAPINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, MIRTAZAPINE, PREGABALIN, SERTACONAZOLE NITRATE, CLONAZEPAM, RISPERIDONE, |
||||
| 32 | 25141341 |
US |
71 | 2 |
Hospitalisation, Product dose omission issue, Off label use, |
||||
FOSTAMATINIB, |
||||
| 33 | 25141470 |
2 | ||
Hospitalisation, |
||||
LENALIDOMIDE, ACYCLOVIR, BACLOFEN, |
||||
| 34 | 25141491 |
59 | 2 | |
Hospitalisation, |
||||
AVACOPAN, |
||||
| 35 | 25141947 |
|||
Hospitalisation, |
||||
CLONAZEPAM, |
||||
| 36 | 25142139 |
US |
||
Hospitalisation, General physical health deterioration, Product dose omission issue, |
||||
MEPOLIZUMAB, |
||||
| 37 | 25142238 |
US |
2 | |
Hospitalisation, |
||||
FOSTAMATINIB, |
||||
| 38 | 25142744 |
US |
9 | 1 |
Hospitalisation, Hospice care, |
||||
MACITENTAN, |
||||
| 39 | 25142767 |
US |
32 | 2 |
Hospitalisation, |
||||
ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, |
||||
| 40 | 25142776 |
US |
79 | 2 |
Hospitalisation, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 41 | 25142799 |
PR |
66 | 2 |
Hospitalisation, |
||||
LENALIDOMIDE, DARATUMUMAB, |
||||
| 42 | 25142884 |
JP |
||
Hospitalisation, |
||||
EVOLOCUMAB, |
||||
| 43 | 25144596 |
8 | 2 | |
Hospitalisation, |
||||
NIRSEVIMAB, |
||||
| 44 | 25144828 |
|||
Hospitalisation, |
||||
SERTRALINE, |
||||
| 45 | 25145103 |
82 | 1 | |
Hospitalisation, |
||||
RISANKIZUMAB-RZAA, |
||||
| 46 | 25145840 |
77 | 1 | |
Hospitalisation, |
||||
TEMOZOLOMIDE, |
||||
| 47 | 25138168 |
US |
2 | |
Hospitalisation, |
||||
CANNABIDIOL, |
||||
| 48 | 25138598 |
US |
1 | |
Hospitalisation, |
||||
IBRUTINIB, IBRUTINIB, |
||||
| 49 | 25138599 |
US |
82 | 2 |
Hospitalisation, Memory impairment, Medical device implantation, |
||||
PANCRELIPASE, |
||||
| 50 | 25138750 |
AU |
||
Death, Hospitalisation, |
||||
DENOSUMAB, |
||||
| 51 | 25137794 |
US |
32 | 1 |
Hospitalisation, Drug resistance, Drug ineffective, |
||||
DIVALPROEX SODIUM, LITHIUM, LITHIUM BROMATUM, CLOZAPINE, CLONAZEPAM, OLANZAPINE, OLANZAPINE PAMOATE, ZIPRASIDONE HYDROCHLORIDE, ZIPRASIDONE, ZIPRASIDONE MESYLATE, HALOPERIDOL, HALOPERIDOL LACTATE, TEMAZEPAM, |
||||
| 52 | 25137833 |
GB |
||
Hospitalisation, Illness, Intentional dose omission, |
||||
ADALIMUMAB-AATY, |
||||
| 53 | 25137895 |
JP |
||
Hospitalisation, |
||||
MIGLUSTAT, |
||||
| 54 | 25138058 |
US |
2 | |
Hospitalisation, |
||||
CANNABIDIOL, CANNABIDIOL, |
||||
| 55 | 25138059 |
US |
7 | 2 |
Hospitalisation, |
||||
CANNABIDIOL, |
||||
| 56 | 25138062 |
US |
1 | |
Hospitalisation, Off label use, |
||||
CANNABIDIOL, CANNABIDIOL, CANNABIDIOL, POLYETHYLENE GLYCOL 3350, FLUTICASONE PROPIONATE, ERGOCALCIFEROL, CLONAZEPAM, |
||||
| 57 | 25132043 |
US |
||
Hospitalisation, |
||||
PALIPERIDONE, |
||||
| 58 | 25132045 |
JP |
||
Hospitalisation, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 59 | 25132214 |
CA |
2 | |
Asthenia, Depression, Dizziness, Impaired work ability, Insomnia, Musculoskeletal stiffness, Mycobacterium avium complex infection, Nausea, Hospitalisation, |
||||
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, AMIKACIN SULFATE, |
||||
| 60 | 25132351 |
ZA |
||
Hospitalisation, |
||||
INFLIXIMAB, |
||||
| 61 | 25132375 |
US |
1 | |
Hospitalisation, Renal injury, Stress, Anxiety, Cardiac disorder, Depression, Mental disorder, Delusion, Illness, Nervousness, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 62 | 25132394 |
GB |
1 | |
Hospitalisation, |
||||
DARBEPOETIN ALFA, |
||||
| 63 | 25133112 |
US |
47 | 2 |
Hospitalisation, |
||||
ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, |
||||
| 64 | 25133356 |
US |
2 | |
Hospitalisation, |
||||
INSULIN DEGLUDEC, |
||||
| 65 | 25133370 |
US |
||
Hospitalisation, |
||||
| 66 | 25133437 |
US |
8 | 2 |
Hospitalisation, |
||||
TRIPTORELIN, TRIPTORELIN, MONTELUKAST SODIUM, CETIRIZINE HYDROCHLORIDE, |
||||
| 67 | 25133453 |
CA |
51 | 2 |
Hospitalisation, |
||||
ZOLEDRONIC ACID, |
||||
| 68 | 25133604 |
US |
50 | 2 |
Hospitalisation, |
||||
RIFAXIMIN, |
||||
| 69 | 25133847 |
US |
59 | 2 |
Hospitalisation, |
||||
POMALIDOMIDE, |
||||
| 70 | 25134000 |
US |
73 | 1 |
Hospitalisation, |
||||
LENALIDOMIDE, |
||||
| 71 | 25134116 |
JP |
||
Hospitalisation, |
||||
DARBEPOETIN ALFA, |
||||
| 72 | 25134914 |
US |
16 | 1 |
Hospitalisation, Infection, Dehydration, Pyrexia, |
||||
DUPILUMAB, |
||||
| 73 | 25134947 |
US |
49 | 2 |
Hospitalisation, Oral candidiasis, |
||||
DUPILUMAB, DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ADALIMUMAB, MONTELUKAST, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, FLUTICASONE PROPIONATE, ROPINIROLE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE, ISOSORBIDE MONONITRATE, BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES, AZELASTINE HYDROCHLORIDE, AZELASTINE, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUDESONIDE, CETIRIZINE HYDROCHLORIDE, TIOTROPIUM BROMIDE INHALATION SPRAY, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, SEMAGLUTIDE, HYDROXYZINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, RIVAROXABAN, METHYLPREDNISOLONE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, PROMETHAZINE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, BUTALBITAL AND ACETAMINOPHEN, BUTALBITAL AND ACETAMINOPHEN TABLETS, TIZANIDINE, |
||||
| 74 | 25135155 |
US |
1 | |
Hospitalisation, |
||||
ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, SACUBITRIL AND VALSARTAN, PREDNISONE, POTASSIUM CHLORIDE, |
||||
| 75 | 25135221 |
GB |
||
Hospitalisation, |
||||
CLOZAPINE, |
||||
| 76 | 25135228 |
US |
1 | |
Hospitalisation, |
||||
SPARSENTAN, |
||||
| 77 | 25135430 |
AU |
73 | 1 |
Death, Hospitalisation, |
||||
DENOSUMAB, |
||||
| 78 | 25135493 |
US |
34 | 2 |
Hospitalisation, Device defective, Product dose omission issue, |
||||
GUSELKUMAB, |
||||
| 79 | 25135525 |
|||
Hospitalisation, |
||||
INTERFERON BETA-1B, |
||||
| 80 | 25136142 |
US |
2 | |
Hospitalisation, |
||||
AFLIBERCEPT, AFLIBERCEPT, |
||||
| 81 | 25136160 |
US |
||
Hospitalisation, Influenza, Product dose omission issue, |
||||
MEPOLIZUMAB, |
||||
| 82 | 25136234 |
|||
Hospitalisation, |
||||
TIRZEPATIDE, |
||||
| 83 | 25136482 |
US |
60 | |
Hospitalisation, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
| 84 | 25136664 |
US |
62 | 1 |
Hospitalisation, |
||||
| 85 | 25140302 |
35 | 2 | |
Hospitalisation, |
||||
UPADACITINIB, |
||||
| 86 | 25140927 |
70 | 1 | |
Hospitalisation, |
||||
ABALOPARATIDE, |
||||
| 87 | 25126386 |
US |
1 | |
Hospitalisation, Emergency care, |
||||
CANNABIDIOL, |
||||
| 88 | 25126584 |
US |
1 | |
Hospitalisation, |
||||
VIGABATRIN, LEVOCARNITINE, LEVOCARNITINE ORAL, CYPROHEPTADINE HYDROCHLORIDE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, ZONISAMIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), ALBUTEROL SULFATE, POTASSIUM CITRATE, |
||||
| 89 | 25126732 |
US |
76 | 1 |
Hospitalisation, Off label use, |
||||
POMALIDOMIDE, |
||||
| 90 | 25126733 |
US |
69 | 2 |
Hospitalisation, |
||||
POMALIDOMIDE, |
||||
| 91 | 25127300 |
US |
2 | |
Hospitalisation, Atrial fibrillation, Dizziness, Therapy interrupted, Presyncope, Haemoptysis, |
||||
SELEXIPAG, AMBRISENTAN, |
||||
| 92 | 25127466 |
ZA |
74 | 2 |
Cardiac disorder, Hospitalisation, |
||||
FENOFIBRATE, VERAPAMIL HYDROCHLORIDE, CLONAZEPAM, ROSUVASTATIN, LEVOTHYROXINE, ASPIRIN, |
||||
| 93 | 25127519 |
CA |
24 | 2 |
Hospitalisation, |
||||
ADALIMUMAB-RYVK, |
||||
| 94 | 25127555 |
US |
70 | 2 |
Hospitalisation, Off label use, |
||||
LENALIDOMIDE, |
||||
| 95 | 25127559 |
US |
1 | |
Hospitalisation, Emergency care, Off label use, |
||||
CANNABIDIOL, VIGABATRIN, |
||||
| 96 | 25127580 |
US |
2 | |
Hospitalisation, Therapy interrupted, Off label use, |
||||
AMIKACIN, AMIKACIN, |
||||
| 97 | 25127781 |
US |
||
Hospitalisation, |
||||
AMBRISENTAN, |
||||
| 98 | 25127782 |
US |
||
Hospitalisation, |
||||
AMBRISENTAN, |
||||
| 99 | 25127783 |
US |
||
Hospitalisation, |
||||
AMBRISENTAN, |
||||
| 100 | 25127784 |
US |
||
Hospitalisation, |
||||
AMBRISENTAN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28